Skip navigation

Refine by Type

Results 1 - 7 of 7 for OBINUTUZUMAB
  1. Obinutuzumab injection is used with chlorambucil (Leukeran) to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Obinutuzumab injection is in a class of medications called ...
  2. ... be an appropriate initial treatment for some patients. Obinutuzumab — Obinutuzumab (brand name: Gazyva) is a monoclonal antibody that targets B lymphocytes. Patients treated with obinutuzumab plus chlorambucil are more likely to respond to ...
  3. ... a monoclonal antibody targeting CD20 like rituximab (Rituxan), obinutuzumab (Gazyva), or ofatumumab (Arzerra). Intermediate- and high-risk ... Oncovin), and prednisone Chlorambucil combined with prednisone, rituximab, obinutuzumab, or ofatumumab PCR: pentostatin (Nipent), cyclophosphamide, and rituximab ...
  4. Drugs Approved for Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... Cytoxan (Cyclophosphamide) Fludara (Fludarabine Phosphate) Fludarabine Phosphate Gazyva (Obinutuzumab) Ibrutinib Imbruvica (Ibrutinib) Leukeran (Chlorambucil) Linfolizin (Chlorambucil) Neosar ( ...
  5. Leukemia Trial Results From the National Institutes of Health (National Cancer Institute)  
    ... who received a placebo plus rituximab. Combination of Obinutuzumab Plus Chlorambucil Improves Survival in Patients with Chronic ... other health conditions who received a combination of obinutuzumab (Gazyva™) and chlorambucil (Leukeran®) lived longer without their ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Top G Gardasil (Recombinant HPV Quadrivalent Vaccine) Gazyva (Obinutuzumab) Gefitinib Gemcitabine Hydrochloride GEMCITABINE-CISPLATIN GEMCITABINE-OXALIPLATIN Gemtuzumab ...
  7. ... the CD22 antigen on certain lymphoma cells, and obinutuzumab, which targets the CD20 antigen. Some newer antibodies ...